Trastuzumab Biosimilars Market: Affordable Access to a Life-Saving...

adicionou um novo artigo Health

2026-10-23 09:06:00 - Traduzir -

Trastuzumab Biosimilars Market: Affordable Access to a Life-Saving Cancer Drug

Trastuzumab transformed HER2-positive breast cancer from one of the most aggressive subtypes into a manageable disease. But for years, its high cost limited access—particularly in lower-income countries and under-resourced health systems. Trastuzumab biosimilars have changed that equation, offering comparable efficacy at substantially lower prices and expanding treatment to patients who...

0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior